Associations Between Insomnia and Large Vessel Occlusion Acute Ischemic Stroke: an Observational Study

Huali Xu,Weili Li,Jiahao Chen,Piao Zhang,Siming Rong,Jinping Tian,Yuqian Zhang,Yanke Li,Zhenzhen Cui,Yuhu Zhang

DOI: https://doi.org/10.1016/j.clinsp.2023.100297

IF: 2.898

2023-01-01

Clinics

Abstract:Objectives: This study explored the association between insomnia and the clinical outcome of large vessel occlu-sion Acute Ischemic Stroke (AIS) and attempted to explore its potential mechanisms from the perspectives of inflammation and oxidative stress.Methods: AIS patients who underwent endovascular treatment for large vessel occlusion at Binzhou Central Hospi-tal from 2018 to 2022 (n = 508) were included. Patients were divided into an insomnia group and a non-insom-nia group. Insomnia was judged by self-reported Athens Insomnia Scale score. Regression analysis was used to compare the differences in the 24-hour and 7-day National Institutes of Health Stroke Scale (NIHSS) score, Early Neurological Deterioration (END), early adverse event incidence, 90-day prognosis and mortality, and serum bio-markers levels.Results: The incidence of insomnia in the study population was 39.6% (n = 144, insomnia group; n = 364, non-insomnia group). Compared with the non-insomnia group, a worse prognosis outcome (63% vs. 49%, adjusted rate ratio: 1.8, 95% Confidence Interval: 1.2-3.7; p = 0.016), higher 24-h and 7-day NIHSS score (17 [9-36] vs. 13 [5-20]; p = 0.024, and 11 [4-24) vs. 8 [2-14]; p = 0.031, respectively), higher END (24% vs. 15%, p = 0.022), and higher incidence of adverse events were observed in the insomnia group (79% vs. 59%, p = 0.010). The 90-day mortality was higher in the insomnia group than that in the non-insomnia group (22% vs. 17%), however, such a difference was not statistically significant.Conclusion: Insomnia is closely related to the clinical outcome of AIS with large vessel occlusion, and inflamma-tion and oxidative stress mechanisms may be involved.